They also reported that inhibiting the activity of SIRT1 in HCC had a cytostatic effect in vitro, which is characterized by impaired cell proliferation, and results in impaired tumor cell growth in vivo [54]. Here, SIRT1 is linked to hepatocellular carcinoma.